Global Alopecia Market

Alopecia Market Size, Share, Growth Analysis, By Disease type(Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), By Treatment(Pharmaceuticals, Devices), By Gender(Male, Female), By Sales Channel(Prescriptions, OTC), By End Use(Homecare setting, dermatology clinics), By Region - Industry Forecast 2024-2031


Report ID: SQSG35I2021 | Region: Global | Published Date: April, 2024
Pages: 165 | Tables: 141 | Figures: 78

Alopecia Market Regional Insights

In 2021, North America dominated the market and had the highest revenue share (36.3%). High disease prevalence, rising consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure all contribute to the growth. A major driver of the market's expansion is the existence of important players in this area. Additionally, the region is seeing an increase in the number of people receiving laser-based therapy to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that provide guidelines and raise public awareness are also likely to have a positive effect on the market.

The market is expected to grow at the highest CAGR in Asia Pacific during the forecast period as a result of rising consumer awareness, disposable income, and product penetration in the region for alopecia. Additionally, it is expected that enhancing the healthcare regulatory environment in emerging nations will draw in foreign investors and open up new business opportunities. For instance, China's regulatory body, the China Food and Drug Administration, authorised the iGrow laser system by Apira Science in 2021, making it the country's first ever laser-based hair growth technology.

During the forecast period, Europe is also expected to hold a sizable market share. Many things, including technology developments and awareness programmes run by both governmental and commercial organisations, might be blamed for this surge. The European Hair Research Society plays a significant role in organising campaigns to raise awareness of hair loss research and efficient treatments for preventing hair loss.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

US Alopecia Market is poised to grow at a sustainable CAGR for the next forecast year.

Due to rising knowledge of alopecia treatments and increased acceptance of alopecia treatment products, Asia-Pacific offers lucrative prospects for key players operating in the alopecia treatment market. Additionally, the expansion of hospitals with cutting-edge medical facilities, and improvement in healthcare infrastructure, progress in the R&D sector, an increase in healthcare reforms, and technical developments in the healthcare industry all contribute to the market's expansion. 'Johnson & Johnson', 'Merck & Co.', 'Pfizer Inc.', 'Cipla Limited', 'Dr. Reddy's Laboratories Ltd.', 'Sun Pharmaceutical Industries Ltd.', 'GlaxoSmithKline plc', 'Aclaris Therapeutics, Inc.', 'Concert Pharmaceuticals, Inc.', 'HCell Inc.', 'Follica, Inc.', 'Histogen Inc.', 'Allergan plc', 'Bayer AG', 'Kythera Biopharmaceuticals, Inc.', 'Polichem S.A.', 'Takeda Pharmaceutical Company Limited', 'Almirall, S.A.', 'Perrigo Company plc', 'Vegalab, Inc.'

The market for alopecia areata is expected to rise as hair loss becomes more common. According to the American Academy of Dermatology Association (AAD), around 30 million women and 50 million men in the US were estimated to have alopecia in 2021. Around 60% of people experience hair thinning, with pattern hair loss being the most prevalent kind of hair loss in both men and women, according to the Journal of Clinical and Diagnostic Research (JCDR). Additionally, regardless of gender, 2% of the general population is susceptible to developing alopecia areata in their lifetime

Alopecia can be treated with a variety of medications and surgical procedures, including hair transplantation, scalp reduction surgery, and others. The alopecia treatment market is predicted to grow significantly over the forecast period due to factors including an increase in the incidence and prevalence of chronic diseases like arthritis, Polycystic Ovary Syndrome (PCOS), cancer, and others; a change in lifestyle and an increase in stress; an increase in the population of elderly people; hormonal imbalances and unhealthy diets; and an increase in demand for alopecia treatment drugs. Additionally, during the projected period, there is expected to be attractive market expansion prospects due to the growing areas' sizable market potential.

In 2021, North America dominated the market and had the highest revenue share (36.3%). High disease prevalence, rising consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure all contribute to the growth. A major driver of the market's expansion is the existence of important players in this area. Additionally, the region is seeing an increase in the number of people receiving laser-based therapy to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that provide guidelines and raise public awareness are also likely to have a positive effect on the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Alopecia Market

Report ID: SQSG35I2021

$5,300
BUY NOW GET FREE SAMPLE